Considerations for the New Four-Month Rifapentine-Moxifloxacin Regimen for Drug-Susceptible TB in the U.S.

Regimen for Drug-Susceptible TB. Go to Webinar

Presented on September 21, 2021 by the TB Centers of Excellence and the Centers for Disease Control and Prevention

Author:

Rutgers Global Tuberculosis Institute

Format:

Webinar/Podcast

Publication Date:

2021

ID:

362336

Focus Area

TB

Topic

TB Treatment

Related Materials

Materials

Hỏi Đáp về Bệnh Lao Tuberculosis [Questions and Answers About Tuberculosis]

Materials

Katanungan At & Sagot Tungkol Sa Tuberkulosis [Questions and Answers About Tuberculosis]

Materials

Questions et réponses sur la tuberculose [Questions and Answers About Tuberculosis]

Materials

Global Tuberculosis Report 2024

Back to Results

Was this page helpful? Give Feedback